P

Perpetual Succour Hospital | Cebu Cancer Institute - Oncology Department

Research site

(Unclaimed)

Location

12th Floor, Our Mother of Perpetual Succour Specialty Center, Cebu City, Cebu, Philippines

Site insights

Top conditions

Top treatments

Pregabalin

Bevacizumab

Farletuzumab

Pegcetacoplan

Taxane

Tofacitinib

ANX005

Azvudine

Platinum

Adalimumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 14 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling

Atrial Fibrillation

Drug: Apixaban Placebo

Drug: Milvexian

Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19

A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection...

Enrolling

SARS-CoV-2 Infection

Drug: Azvudine

Drug: Placebo

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

The purpose of this Proof of Concept (PoC) and Dose-finding (DF) basket study is to evaluate the efficacy and safety of orally administered Enpatoran...

Active, not recruiting

Systemic Lupus Erythematosus

Drug: Placebo

Drug: Enpatoran low dose